论文部分内容阅读
目的比较冠心病(CHD)患者介入治疗(冠状动脉PTCA及支架置入术)及药物治疗预后的差异。方法对上述两种治疗方法治愈出院的90例CHD患者进行随访研究,其中介入治疗组45例,药物治疗组45例。结果患者出院1年后两组远期疗效比较,介入治疗组明显有效(胸闷、胸痛等临床症状消失)33例,有效(临床症状减轻)11例,发生心脏事件1例,无死亡病例,心脏事件发生率为2.2%;药物治疗组显著疗效19例,有效14例,发生心脏事件12例,死亡2例,心脏事件发生率为26.6%。两组比较差异有统计学意义(P<0.01)。结论与药物治疗者比较,冠心病患者在行介入治疗后,远期疗效明显增高,心脏事件发生率明显降低。表明冠心病患者及早行介入治疗,可提高其生存率和生活质量。
Objective To compare the differences of interventional therapy (coronary PTCA and stent implantation) and drug treatment prognosis in patients with coronary heart disease (CHD). Methods The follow-up study of 90 CHD patients who were cured and discharged from the above two treatment methods was conducted. Among them, 45 were involved in the treatment group and 45 were in the drug treatment group. Results The long-term efficacy of the two groups after discharge from the hospital for one year was significantly higher in the intervention group than in the intervention group (33 with clinical symptoms such as chest tightness and chest pain disappeared), 11 with effective (clinical symptom relief), 1 with cardiac event, no death, The incidence of the incident was 2.2%. In the drug treatment group, 19 cases were significantly treated, 14 cases were effective, 12 cases were cardiac events, 2 cases died and the incidence of cardiac events was 26.6%. The difference between the two groups was statistically significant (P <0.01). Conclusion Compared with the drug treatment, patients with coronary heart disease after interventional treatment, the long-term efficacy was significantly increased, the incidence of cardiac events decreased significantly. Show that patients with coronary heart disease and early intervention can improve their survival rate and quality of life.